The effect of continuous ambulatory peritoneal dialysis on change in serum leptin

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Kim, Dae Joong ^a,b   Oh, Dong Jin ^b   Kim, Bum ^b   Lim, Young Hee ^b   Kang, Woo Heon ^b   Lee, Bang Hoon ^b   Lee, Sung Ku ^b   Huh, Wooseong ^b   Kim, Sang Eun ^a   Lee, Moon Kyu ^a   Kang, Soon Ah ^b   Oh, Ha Young ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Fat mass; Leptin; Weight gain

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; INSULIN; LEPTIN; UREA;

ADULT; AGED; BLOOD LEVEL; BODY FAT; BODY MASS; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0033372252     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901902s27     Document Type: Conference Paper

References (19)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedmann JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372:425-32.
2. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995; 269:546-9.
3. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Rabinowitz D, Lallone RL, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995; 269:543-6.
4. Stephens TW, Basinski M, Bristow PK, Bue-Yalleskey JM, Burgett SG, Craft L, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995; 377:530-2.
5. Considine RV, Sinha K, Heiman ML, Kriauciunas A, Stephens TW, Nyce NR, et al. Serum immunoreactive-leptin concentration in normal-weight and obese humans. N Engl J Med. 1996; 334:292-5.
6. Lusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes. 1995; 44:1467-70.
7. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Land M. Plasma leptin and insulin relationship in obese and nonobese humans. Diabetes. 1996; 45:695-8.
8. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 1998; 18:213-15.
9. Sharma K, Considine RV, Michael B, Dunn SR, Lawrence S, Brenda W, et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int. 1997; 521:1980-5.
10. Heimbürger O, Nordfors L, Lönnqvist F, Danielsson A, Schalling M, Stenvinkel P. High serum leptin levels and down-regulation of ob-gene expression in peritoneal dialysis (PD) patients. Perit Dial Int. 1998; 18:112.
11. Stenvinkel P, Heimbürger O, Lönnqvist F. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant. 1997; 12:1321-5.
12. Ikizler T, Greene J, Wingard R, Parker R, Hakim R. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol. 1995; 6:1386-91.
13. Merabet E, Dagogo JS, Coyne DW, Klein S, Santiago JV, Hmiel SP, et al. Increased plasma leptin concentrations in end-stage renal disease. J Clin Endocrinol Metab. 1997; 82:847-50.
14. Howard JK, Lord GM, Clutterbuck EJ, Ghatei MA, Pusey CD, Bloom SR. Plasma immunoreactive leptin concentration in end-stage renal disease. Clin Sci (Colch). 1997; 93:119-26.
15. Heimbürger O, Lönnqvist F, Danielsson A, Nordenstrom J, Stenvinkel P. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol. 1997; 8:1423-30.
16. Johansen KL, Mulligan K, Tal V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol. 1998; 9:1080-4.
17. Boden G, Chen X, Kolaczynski JW, Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest. 1997; 100:1107-13.
18. Lameire N, Matthys D, Matthys E, Beheydt R. Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol. 1988; 30(Suppl 1):S53-8.
19. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes. 1998; 47:544-9.